. Chronic PKC-␤ activation in HT-29 Cl.19a colonocytes prevents cAMP-mediated ion secretion by inhibiting apical membrane current generation.
VIRAL AND BACTERIAL TOXINS that mobilize intracellular Ca 2ϩ have been shown to stimulate downstream signaling pathways linked to PKC (30, 57) . In the case of rotavirus infection, Ca 2ϩ mobilization by virus entry (54) or by phospholipase C stimulation through extracellular exposure to the viral enterotoxin NSP4 (18) has been proposed to effect cellular PKC signaling (30, 44) . Hence, Ca 2ϩ -and diacyglycerol (DAG)-sensitive PKC activation may participate in the mucosal cell anion permeability and ion transport changes recorded in virally infected mucosal cells (44) and in mucosal sheets treated with NSP4 (36) . To further address this hypothesis in a simplified in vitro assay, we undertook studies in the colonocyte epithelial cell line HT-29 Cl.19A to determine whether the activation status of specific PKC isoforms directly or indirectly promoted cAMP-regulated Cl Ϫ secretion. cAMP-dependent Cl Ϫ secretion in this and other gastrointestinal models is dependent on the apical membrane expression of the anion channel CFTR (2) . The CFTR transport protein is characterized by two roughly similar halves, each incorporating six putative transmembrane ␣-helixes followed by an intracellular nucleotidebinding domain. Unique to CFTR is a large intracellular regulatory domain containing multiple sites for phosphorylation by PKA and PKC (22) , which facilitate changes in channel gating.
The PKC family of serine/threonine kinases is involved in the regulation of many aspects of cell growth, differentiation, and function (8) . The role of generalized PKC activation in epithelial fluid transport as well as cation (K ϩ channel)-and anion (CFTR activation and priming)-dependent Cl Ϫ secretion has been the subject of a number of excellent studies at the protein/molecular levels (23, 60) . In the context of epithelial chloride secretion, 4␤-phorbol ester stimulation of PKC isoforms has been implicated in the regulation of both apical and basolateral plasma membrane ion transport. The best-studied basolateral phenomena relate to the ability of PMA to inhibit basolateral K ϩ efflux and thereby reduce the cell's ability to maintain a sustained electrochemical gradient for Cl Ϫ exit through the concerted efforts of basolateral Na ϩ -K ϩ -ATPase, the Na ϩ -2Cl Ϫ -K ϩ cotransporter, and open apical membrane CFTR Cl Ϫ channels (59, 66) . Supporting a predominantly inhibitory role for PKC signaling in basolateral membrane transport, other reports have implicated phorbol ester-stimulated PKC isoforms as regulators of these same basolateral transport components at the levels of either protein function and/or plasma membrane expression (10, 15, 19, 40) . At the apical plasma membrane, phorbol ester-dependent PKC activation in polarized epithelial cells has been shown to potentiate cAMP-responsive Cl Ϫ current generation via phosphorylationdependent priming of PKA-mediated channel gating (27, 67) , and a subset of CFTR molecules (those isolated from Necturus and Xenopus) has been shown to contain a unique CFTR regulatory domain phosphorylation site, absent in human CFTR, that can directly stimulate channel function (11) . However, PKC does not appear to directly stimulate CFTR anion channel function, and chronic exposure to nonisoform-specific PMA has been shown to downregulate cAMP-dependent Cl Ϫ transport in many epithelial cell lines through decreased CFTR mRNA and protein levels (6, 58, 64) . A recent coimmunoprecipitation study (35) has shown that PKC-⑀ and CFTR are colocalized in a signaling complex through association with the scaffold protein RACK1, suggesting that at least one phorbol ester-sensitive, Ca 2ϩ -independent, DAG-activated (i.e., novel) PKC isoform participates in the local regulation of CFTR at the apical membrane.
Although individual phorbol ester-sensitive PKC isoforms (8) are also implicated in a variety of basolateral ion transport phenomena (21) , electrophysiological transport studies linking PKC isoform participation in the apical plasma membrane to cAMP-dependent secretory current generation have not been performed. We addressed this question in a companion study (9a) .
MATERIALS AND METHODS
Materials. FBS, DMEM, penicillin-streptomycin, and trypsin-EDTA solutions were procured from GIBCO-BRL (Grand Island, NY). Isoform-specific anti-PKC-␣, -␤ 1, -␤2, and -␥ polyclonal antibodies were purchased from Santa Cruz Biotechnology and Upstate Biotechnology. The conventional PKC-specific activator 12-deoxyphorbol 13-phenylacetate 20-acetate (DOPPA) and inhibitor (Gö6976) along with PMA were obtained from Alexis (San Diego, CA). All other chemicals were purchased from Sigma (St. Louis, MO) and were reagent grade unless otherwise specified.
Cell culture. The human colon carcinoma cell line HT-29 Cl.19A was the generous gift of C. L. Laboisse (3) (Institut National de la Santé et de la Recherche Médicale, Paris, France) and was cultured in DMEM supplemented with 4.5 g/l glucose, 10% FBS, 100 U/ml penicillin, and 100 g streptomycin. Cells were grown at 37°C in a humidified atmosphere of 5% CO 2-95% air.
Treatment of cells with PKC modulators. Cells were grown to near confluence on 12-mm sterile filters (Millicell-HA, Millipore; Bedford, MA) in DMEM with 10% FBS. The medium was replaced with DMEM without serum for 2 h before each experiment and then replaced with 1 ml of serum-free medium containing (dissolved in 50 l DMSO) PMA (0.01-1M), DOPPA (1-500 nM), Gö6976 (1-5 M), or carrier alone for 10 min to 48 h. To ensure that significant cellular metabolism of DOPPA to the nonspecific activator 12-deoxyphorbol-13-phenylacetate (DOPP) did not occur, we exchanged DOPPA incubation media every 4 -6 h (29).
Short-circuit current measurement. The 12-mm filter units containing the HT-29 Cl.19A monolayers were placed into custom-designed Ussing chambers (Iowa City, IA). All experiments were carried out at 37°C. Standard Krebs bicarbonate saline solution containing (in mM) 125 NaCl, 4.7 KCl, 1.13 MgCl 2, 25 NaHCO3, 1.15 Na2HPO4, and 10 glucose (pH 7.2) was added, and the monolayers were gassed with 95% O 2-5% CO2 by airlift circulators. The transepithelial potential difference was clamped to zero, and the short-circuit current (ISC) was continuously displayed on a pen recorder. Transepithelial conductance was calculated from the magnitude of the current deflections in response to a bipolar voltage pulse imposed every 60 s with a duration of 0.5 s. For curve fitting results, we employed an iterative regression procedure using the Marquartdt-Levenberg algorithm (Sigmaplot version 4.0, SPSS; Chicago, Il). Dose or time of agonist preincubation versus monolayer I SC response curves were fitted with a threeparameter single-exponential decay [y ϭ ae
function. Agonist concentration versus percent inhibition curves were fitted with a three-parameter logistic sigmoidal [y ϭ a/1 ϩ (x/x o) b , curve fit 2] function. In both instances, x and y are horizontal and vertical ordinates, respectively, x o is the maximal value of x with no inhibition, and a, b, and c are the parameters of amplitude, rate, and inflection, respectively. Identical curve fits were used for related procedures.
PKC abundance measurement by Western blot analysis. Crude homogenates were prepared by homogenization in detergent buffer containing (in mM) 50 Tris ⅐ HCl, 250 sucrose, 2 EDTA, 1 EGTA (pH 7.5), and 10 2-mercaptoethanol with 0.5% Triton X-100 plus protease inhibitor cocktail (PIC) followed by a low-speed spin (15,000 g for 15 min). The clear supernatant was saved as the Triton X-100-solubilized total cell extract. For total cellular extracts including the Triton X-100-insoluble fraction, crude homogenates were extracted with the same buffer containing 0.5% SDS. Subcellular membrane and cytosolic fractions were extracted from similar cells by the omission of detergent and by centrifugation at 100,000 g. The resulting pellet was then detergent extracted in buffer containing (in mM) 10 Tris ⅐ HCl, 140 NaCl, 25 KCl, 5 MgCl 2, 2 EDTA, and 2 EGTA, with 1% Triton X-100 plus PIC (pH 7.5), and the solubilized membrane fraction was collected by centrifugation. The protein concentration was measured in all fractions before electrophoresis was performed, and mouse brain homogenates were used as positive controls. Individual fractions (30 g protein/lane) were subjected to 10% SDS-PAGE and electrotransferred to nitrocellulose membranes. The transfer efficiency was checked by back staining gels with Coomassie blue and/or by reversible staining of the nitrocellulose membrane with Ponceau S solution; no variability was noted. Destained membranes were blocked with 5% nonfat dried milk in Tris-buffered saline [TBS; 20 mM Tris ⅐ HCl and 137 mM NaCl (pH 7.5)] for 1 h at room temperature and then overnight at 4°C. Immunoantigens were detected by incubating the membranes for 2 h with PKC isoform/CFTR antibodies (0.5-1.0 g/ml in TBS containing 0.1% Tween 20, Sigma Chemical). After being washed, membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG or rat anti-mouse IgG and developed using the ECL detection system (Amersham; Arlington Heights, IL) according to the manufacturer's instructions.
Data analysis. All summary results are presented as arithmetic means Ϯ SE. Differences between control and treatment data were analyzed using Student's t-test (Excel, Microsoft; Redmond, WA). The probability of making a type I error Ͻ0.05 was considered statistically significant.
RESULTS
To examine the effect of isoform-specific PKC-␤ activation on CFTR-dependent cellular anion transport, we measured Cl Ϫ secretion in response to elevated cellular cAMP levels in HT-29 Cl.19A monolayers exposed to weak (DOPPA) or strong (PMA) exogenous PKC agonists.
DOPPA inhibited forskolin-stimulated I SC across intact monolayers in a concentration-dependent manner. In the HT-29 Cl.19A subclone, cAMP-responsive transepithelial I SC under standard high-extracellular Na ϩ conditions reflects electrogenic Cl Ϫ secretion into the mucosal bath, as demonstrated by Ussing-chamber and patch-clamp measurements (4, 5, 42, 66) . DOPPA, a specific PKC-␤ agonist (55) with 40-fold less potency than the unselective parental compound PMA (38) , was employed to delineate the role of low level cellular PKC activation on cellular cAMP-regulated Cl Ϫ secretion. Monolayers grown to confluence on filters for 14 -20 days were treated for 24 h with 1-500 nM DOPPA, and changes in transcellular cAMP-dependent I SC (I SC -cAMP) were monitored in response to the cAMP-generating agonist forskolin (FSK; 10 M) alone or in combination with the Ca 2ϩ -mobilizing agonist carbachol (CCh; 50 M).
In intact monolayers, DOPPA inhibited FSK-stimulated transcellular I SC -cAMP in a concentration-dependent manner [ Fig. 1 , A and B (see MATERIALS AND METHODS for curve fit 1)]. These effects were independent of monolayer resistance, which in fact rose slightly between 10 and 100 nM DOPPA before decreasing modestly at DOPPA concentrations of Ͻ200 nM ( Table 1 ). The combined CCh and FSK response was biphasic with the intact basolateral membrane providing a Ba 2ϩ -sensitive component.
The inhibitory effects of DOPPA on transcellular I SC -cAMP are shown more clearly in Fig. 2A . When the results were replotted as percent inhibition of the untreated response (Fig.  2B) , the ID 50 under these conditions was 71 nM (see MATERIALS AND METHODS for curve fit 2). In paired monolayers exposed consecutively to FSK and CCh, a biphasic concentration versus transcellular I SC -cAMP response was recorded (Fig. 1B) . At low (Ͻ30 nM) DOPPA concentrations, any reduction in transcellular I SC -cAMP was compensated for in the combined agonist response by an increase in transcellular I SC -cAMP promoted by the subsequent addition of CCh ( Fig. 2A) . In this concentration range, responses were not significantly different from non-DOPPA-treated monolayers (P Ͼ 0.05). 64Ϯ6  250Ϯ35  123Ϯ9  219Ϯ68  16Ϯ3  290Ϯ60  12  10  6Ϯ3  385Ϯ52  67Ϯ7  278Ϯ87  132Ϯ6  234Ϯ86  21Ϯ4  242Ϯ86  10Ϯ6  300Ϯ69 20Ϯ7  468Ϯ80  24  20  6Ϯ5  385Ϯ50  54Ϯ7  286Ϯ56  131Ϯ6  210Ϯ57  20Ϯ3  248Ϯ60  15  30  2Ϯ3  400Ϯ58  56Ϯ5  236Ϯ70  123Ϯ5  242Ϯ56  12Ϯ3  288Ϯ56  12  50  9Ϯ4  400Ϯ49  53Ϯ7  340Ϯ27  119Ϯ6  284Ϯ30  21Ϯ3  204Ϯ30  13Ϯ2  386Ϯ30 16Ϯ6  480Ϯ30  58  100  3Ϯ3  333Ϯ45  26Ϯ3  368Ϯ82  63Ϯ3  238Ϯ82  13Ϯ4  259Ϯ80  7Ϯ3  360Ϯ62  7Ϯ4  446Ϯ72  60  200  9Ϯ4  285Ϯ58  20Ϯ4  252Ϯ73  31Ϯ3  234Ϯ70  13Ϯ4  243Ϯ70  12  500  7Ϯ2  200Ϯ38  11Ϯ3  191Ϯ24  14Ϯ2  192Ϯ24  14Ϯ3  198Ϯ30  7Ϯ3  210Ϯ44  24 Values are means Ϯ SE; n, total no. of experiments performed. The agonists forskolin (FSK; 10 M) and carbachol (CCh; 50 M) were added consecutively to the bilateral (mucosal and serosal) and unilateral (serosal) baths, respectively. Transepithelial short-circuit current (ISC; in A/cm 2 ) and resistance (R; in ⍀/cm 2 ) were recorded during agonist stimulation in untreated control (0 nM) and 1-500 nM 24-h 12-dioxyphorbol 13-phenylacetate 20-acetate (DOPPA)treated monolayers. Bumetanide (Bumet; 400 M) was then added to the serosal bath for 96 control monolayers, 16 monolayers preexposed to 1 nM DOPPA, 12 monolayers preexposed to 10 nM DOPPA, and 24 monolayers each preexposed to either 50 or 100 nM DOPPA. As additional controls, diphenylamine-2-carboxylate (DPC; 2 mM) was added to the mucosal baths of 8 control monolayers, 4 monolayers preexposed to 10 nM DOPPA, and 24 monolayers each preexposed to either 50 or 100 nM DOPPA. In other instances, serosal bath [Cl Ϫ ] was lowered to 7 mM (ϩ lowered [Cl Ϫ ]s), thereby decreasing the transepithelial (serosal to mucosal) Cl Ϫ gradient in 8 control monolayers, 8 monolayers preexposed to 10 nM DOPPA, and 10 -12 monolayers each preexposed to either 50 or 100 nM DOPPA, respectively. BaCl2 (2 mM) added to the serosal side of monolayers inhibited cAMP-stimulated ISC by 61% (n ϭ 12; data not shown). (Table 1) . Identical studies were performed in age-matched monolayers exposed on their serosal bath surface (basolateral plasma membrane) to the univalent ion pore-forming antibiotic nystatin (50 g/ml; Fig. 3 and Table 2 ).
Monolayers exhibiting basal transepithelial resistance within the 300 -500 ⍀/cm 2 range were selected for these studies (Table 2) . After 24 h of incubation with either carrier alone (control) or 1-500 nM DOPPA, monolayers were then bathed in standard high-Na ϩ -Krebs saline with a 140:7 mM mucosalto-serosal Cl Ϫ gradient (Fig. 3A ). An initial challenge with 10 M FSK resulted in a small I SC -cAMP against the prevailing anion gradient, which inverted after nystatin permeabilization of the basolateral plasma membrane into a large absorptive current [ Irrespective of whether DOPPA preincubation occurred, the net ISC produced by the combined agonists (1 ϩ 2) was identical. In contrast, cAMP-dependent ISC (ISC-cAMP) was clearly attenuated by DOPPA preincubation (1), indicating that larger CCh effects (2) made up this difference during FSK ϩ CCh stimulation. B: when the responses were replotted as the %inhibition of the agonist response in control monolayers, the concentrations of DOPPA required to cause 50% inhibition (ID50) were 69 Ϯ 3 nM for FSK alone (F) and 98 Ϯ 2 nM for FSK ϩ CCh combined (E). At DOPPA concentrations of Ͻ30 nM, the mean combined agonist response was larger than that recorded for untreated monolayers but was not significant (n ϭ 19 -35). were initially maintained with140 mM NaCl in both serosal and mucosal baths. After an equilibration period, a high (140 mM NaCl) mucosal-to-low (7 mM NaCl) serosal bath anion gradient was imposed (i), and the ISC responses to bilateral bath 10 M FSK addition were recorded (ii). Nystatin (50 mg/ml) was then added to the serosal bath to permeabilize the basolateral plasma membrane to univalent ions (iii), and apical plasma membrane-generated ISC was recorded. . When the change in apical membrane I SC -cAMP was plotted against agonist concentration, 1-500 nM DOPPA stepwise inhibited up to 80% of the apical membrane-generated cAMP-dependent Cl Ϫ current [ Fig. 3B ; n ϭ 9 -11 observations for each data point (see MATERIALS AND METHODS for curve fit 1)]. DOPPA incubation did not significantly affect basal transepithelial resistance values until DOPPA concentrations Ͼ200 nM were used (Table 2) .
When resuslts were replotted as percent inhibition, an ID 50 of 65 nM [ Fig. 4 (see MATERIALS AND METHODS for curve fit 2)], close to that recorded in intact monolayers, was estimated (Fig.  2B) . Apical membrane I SC -cAMP measured across 24-h DOPPA (Ͼ30 nM)-treated apical plasma membranes was much smaller than that recorded in the absence of cellular DOPPA preincubation, and both DOPPA-treated and control monolayers exhibited few combined (FSK ϩ CCh) agonist responses (see Fig. 10 ). Thus the stimulatory effects of Ͻ30 nM DOPPA preincubation on CCh-facilitated transcellular I SC -cAMP ( Fig. 1) were dependent on the presence of an intact basolateral plasma membrane, and, because of the Ba 2ϩ sensitivity (16) , were predicted to be K ϩ channel dependent.
DOPPA affected the membrane translocation status and expression levels of individual PKC-␤ isoforms.
To validate that DOPPA was affecting PKC function in our experimental assay, Western blot analysis was used to measure changes in immunospecific phorbol ester-sensitive PKC expression in both cytosolic (non-Triton X-100 extracted) and membraneassociated (Triton X-100 extracted) subcellular fractions. It is widely accepted that PKC exists in an inactive conformation in the cytosol, and, after activation, the enzyme translocates from the cytosol to membranes. The active state is usually held for a short period (minutes to hours for endogenous signaling pathways; much shorter periods when exogenous agents are used) before the kinase is once again inactivated and returns to the cytosol (8) . Thus, in long-term experiments, the results report on an equilibrium between cellular PKC isoform pools in inactive (cytosolic ϾϾ membrane), active (membrane ϾϾ cytosolic), and postactivation (cytosolic Ͼ membrane) status. Figure 5 shows a representative Western blot (A) and corresponding mean densitometric ratio (B) for the membrane-tocytosolic partitioning ratio [R (membrane/cytosol) ] for all phorbol ester-sensitive PKC isoforms detected in control and DOPPAtreated monolayers. Incubation for 24 h with 50 nM DOPPA failed to induce membrane translocation of Ca 2ϩ -and DAGsensitive PKC-␣/␤ 1 /␥ or Ca 2ϩ -insensitive but DAG-sensitive PKC-⑀. However, a significant reduction in the membrane translocation ratio of PKC-␤ 2 was recorded, an effect caused by increased cytosolic PKC-␤ 2 levels without any corresponding change in the size of the membrane-associated pool. When total cellular levels for each immunodetected isoform were determined, DOPPA preincubation selectively and reciprocally affected cellular PKC ␤-isoform expression; a modest decrease (1.4 Ϯ 0.1-fold) in PKC-␤ 1 and increase (1.6 Ϯ 0.1-fold) in PKC-␤ 2 was recorded [see companion study (9a) ]. The relative expression levels of the other isoforms did not change relative to ␤-actin (n ϭ 3 separate experimental observations). The 
Values are means Ϯ SE; n, total no. of experiments performed. Currents were recorded across the intact apical membrane. Untreated control (0 nM) and 1-500 nM 24-h DOPPA-treated monolayers were utilized for these studies. After an exchange of 140 mM serosal NaCl solution to 7 mM (lowered [Cl Ϫ ]s), monolayers were challenged with a bilateral bath addition of 10 M FSK Nystatin (NYS 50 mg/ml) and CCh (50 M) were added sequentially to the serosal bath. Transapical (ISC A/cm 2 ) was recorded at each transition once steady-state levels were achieved. DPC (2 mM) was added to the mucosal baths of 8 control monolayers, 6 monolayers treated with 10 nM DOPPA, and 8 -12 monolayers each treated with either 50 or 100 nM DOPPA, respectively. In all other instances, mucosal bath [Cl Ϫ ] was lowered to 7 mM (lowered [Cl Ϫ ]m), thereby equalizing the transapical Cl Ϫ gradient (19 control monolayers, 6 monolayers preexposed to 10 nM DOPPA, and 4 -14 monolayers each preexposed to either 50 or 100 nM DOPPA, respectively). Fig. 4 . Inhibition curve detailed in Fig. 3 graphed as percentages of the untreated ISC response, showing that a progressive inhibition occurred at DOPPA concentrations of Ͼ30 nM (n ϭ 9 -12). DOPPA at 10 nM produced a weak but significant (P Ͻ 0.05) percent increase in apical plasma membranegenerated ISC, whereas the ID50 under these conditions was 66 Ϯ 5 nM. percent membrane association [membrane/(cytostol ϩ membrane) ϫ 100] for the PKC-␣, -␤ 1 , -␥, and -⑀ isoforms remained unchanged at 50%, 50%, 28%, and 77%, respectively. The percent membrane association for PKC-␤ 2 decreased from 90% to 70%, demonstrating that a significant fraction remained active when the cytoplasmic PKC-␤ 2 mass increased. Western blots were stripped and reprobed for cytoplasmic ␤-actin, and back staining of SDS gels to check transfer efficiency was routinely performed (see MATERIALS AND METHODS).
The specificity of these effects were consistent with the findings of Khare and colleagues (28) , who showed that monolayers exposed acutely (5-20 min) to 200 nM DOPPA exhibited selective PKC-␤ activation with no change in the activation status of other PKC isoforms. Thus, during the 24-h low-dose DOPPA preincubation, the increased cytoplasmic PKC-␤ 2 partitioning predicted an increase in the postactivation status of the PKC ␤-isoforms. We therefore hypothesized that inhibition of cAMP-dependent apical plasma membrane Cl Ϫ current under these conditions was mediated by PKC-␤ 2 or PKC-␤ 1 homolog-specific changes in subcellular signaling function.
PMA, but not DOPPA, acutely stimulated apical plasma membrane-generated I SC through PKC-␣ or PKC-␤ interactions with CFTR Cl Ϫ channels. Intact or basolateral membrane-permeabilized HT-29 Cl.19A monolayers exposed acutely to either 50 nM DOPPA or 1 M Gö6976 (a selective PKC-␣/␤ inhibitor) did not exhibit any change in I SC (Table 3) . In contrast, 50 -500 nM PMA generated significant I SC in both intact and basolateral membrane-permeabilized monolayers. An example of PMA-induced apical membrane I SC -cAMP is shown in Fig. 6 .
Confirming previous reports (4, 5, 65, 66) , PMA acted as a potent agonist (Fig. 6A) . Compared with FSK (Fig. 6B) , PMAinduced I SC exhibited a slower time course for activation [initial rates (R) for PMA and FSK (R ϭ ⌬I SC /⌬T), where T is time, were 0.43 Ϯ 0.4 and 2.8 Ϯ 0.5 A/s, respectively; n ϭ 15 monolayers/experimental condition)]. The overall magnitude of the apical membrane I SC response was also smaller (Fig. 6A and right bar graph) . Increasing the PMA dose from 50 to 500 nM did not significantly (P Ͼ 0.5) increase the rate constant of the stimulated apical membrane I SC (R ϭ 0.52 Ϯ 0.4 A/s) or affect the total magnitude of the combined phorbol ester-and FSK-generated apical membrane I SC -cAMP response (Fig. 6, C, D , and right bar graph). We found that the acute apical membrane I SC stimulated by PMA was largely mediated by PKC-␣/␤ activation because 70% of the PMAevoked DPC-sensitive I SC was blocked by prior monolayer exposure to the highly selective PKC inhibitor Gö6976 (39) ( Table 3 ). This was not the case for FSK, which exhibited nearly normal current levels after chronic (Ͼ60 min) Gö6976 preincubation. However, we did find that 1-min to 2-h Gö6976 monolayer preincubation before FSK inhibited 10 -15% of apical membrane I SC -cAMP (Table 4) , whereas more prolonged treatment (2-24 h) of monolayers failed to affect apical membrane I SC -cAMP generation, similar to Gö6976 application post-FSK challenge (Table 3) . From these findings, we hypothesized that 1) PMA, unlike DOPPA, stimulated apical plasma membrane CFTR function, 2) whereas Gö6976 preexposure significantly reversed PMA-dependent activation of apical plasma membrane resident CFTR, and short-term (Ͻ15 min) but not long-term Gö6976 preexposure before FSK challenge prevented the acute stimulation of a much smaller PKC- Western blots of PKC isoform expression in detergentextracted membrane (m) and cytosolic (c) subcellular fractions isolated from control (blot i) or DOPPA-treated (blot ii) monolayers. Little change in the densitometric appearance of membrane PKC-␣, -␤1, -␥, or -⑀ or cytosolic PKC-␣, -␤1, -␥, or -⑀ was detected, although the cytoplasmic PKC-␤2 band increased. B: corresponding bar graph of membrane-to-cytosolic ratios (densitometric values relative to ␤-actin) recording an ϳ3-fold decrease in the ratio of PKC-␤2 membrane to cytosol association. Changes were significant. Open bars, control monolayers; hatched bars, DOPPA-pretreated monolayers (n ϭ 3, P Ͻ 0.01). Table 3 
. Acute effects of various agents on transepithelial I SC
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Values are means Ϯ SE; n, total no. of experiments. The concentrations of agonist/inhibitor used were as follows: 1 M Gö6976, 50 nM DOPPA, 50 nM PMA, and 10 M FSK. Gö6976 was also applied after either a bilateral bath FSK, DOPPA, or PMA addition (ϩGö6976). Initial transepithelial resistances (R; in ⍀/cm 2 ) did not vary significantly (P Ͼ 0.1, n ϭ 132).
sensitive CFTR pool. This pool was sensitive to cellular cAMP levels but not initially associated with the apical plasma membrane (see DISCUSSION) . The PKC-␤ specificity for DOPPA within these monolayers (Fig. 5 ) and in other colonocyte preparations (28) indicates that Gö6976-sensitive PKC-␣ activation was responsible for the acute stimulation of apical membrane I SC by FSK and PMA.
Chronic monolayer exposure to PMA identified both PKC-␤ and PKC-⑀ as candidates for PKC-dependent inhibition of apical plasma membrane-generated I SC -cAMP.
Time-dependent effects of PMA stimulation on transcellular I SC cAMP were investigated in intact 12-day-old monolayers. The potency of this agonist was compared with DOPPA by creating a time course of drug incubation versus change in transcellular I SC -cAMP (Fig. 7) .
Within 2 h, 50 nM PMA reduced the transcellular I SC -cAMP by 86% and at 24 h by 89% [n ϭ 24 (see MATERIALS AND METHODS for curve fit 1)] compared with DOPPA, where currents changed by 18% and 41%, respectively. PMA, unlike DOPPA, caused a 25 Ϯ 5% and 41 Ϯ 3% decrease in basal monolayer resistance at these times (n ϭ 12). When apical membrane I SC -cAMP was measured in 24-h PMA-pretreated monolayers exposed to serosal bath nystatin, a similar steep time-dependent reduction in FSK-stimulated current was recorded ( Fig. 8) .
Monolayers were bathed in high-Na ϩ , bicarbonate-free HEPES-buffered saline in the presence of a 140:7 mM serosalto-mucosal Cl Ϫ gradient. Nystatin permeabilization of the basolateral plasma membrane under these conditions did not in itself elicit apical membrane I SC -cAMP. However, when this was followed in control monolayers by a bilateral bath FSK (10 M) addition, a large apical membrane I SC -cAMP, reflecting current flow along a mucosal-to-serosal electrochemical gradient, was recorded (Fig. 8A) . A 24-h PMA preincubation led to a nearly complete loss of this current (Fig. 8A) , which was not dependent on the direction of the imposed anion gradient: similar inhibition (Ͼ97%) occurred when I SC flowed from the mucosal-to-serosal or serosal-to-mucosal baths (Fig. 8B) . A previous study (65) in HT-29 Cl.19A monolayers demonstrated that chronic PMA exposure does not effect the ability of FSK to raise cAMP levels. Thus the lack of any additive effects between PMA and FSK on apical membrane I SC -cAMP gen- Fig. 6 . Acute effects of PMA on ISC generated by basolateral plasma membrane-permeabilized monolayers. A-D: initially, both mucosal and serosal baths contained 140 mM NaCl. In A-D, serosal bath NaCl was reduced to 7 mM (i), followed by a serosal bath addition of Nystatin (50 mg/ml; ii) and a mucosal bath addition of 1 mM diphenylamine-2-carboxylic acid (DPC; iii). In A and B, the mucosal bath NaCl was subsequently lowered to 7 mM (iv). FSK  59Ϯ3  431Ϯ34  42Ϯ1*  367Ϯ61  46Ϯ1*  387Ϯ38  52Ϯ3  452Ϯ59  50Ϯ5  398Ϯ34  56Ϯ2  433Ϯ40  36  ϩ DPC  9Ϯ1  446Ϯ41  8Ϯ2  420Ϯ45  9Ϯ3  445Ϯ27  10Ϯ1  465Ϯ56  12Ϯ2  410Ϯ24  9Ϯ2  445Ϯ34  PMA  41Ϯ1  398Ϯ45  13Ϯ1*  410Ϯ36  16Ϯ2*  390Ϯ34  11Ϯ1*  357Ϯ36  15Ϯ3*  379Ϯ32  12Ϯ2*  412Ϯ28  36 Values are means Ϯ SE; n, total number of experiments. Intact HT-29 Cl.19A monolayers were treated for varying time periods (0 -1,4440 min) to the highly specific PKC agonist Gö6976 (1 M). Transepithelial ISC (in A/cm
2 ) was measured after a bilateral bath addition of either 10 M forskolin or 50 nM PMA. FSK-stimulated currents were then inhibited by a bilateral bath addition of DPC (2 mM). *Significant effect compared with untreated control (P Ͻ 0.1) eration and a shared DPC sensitivity indicated that the same PKC-sensitive cAMP-responsive anion channel population was being chronically downregulated upon prolonged PMA exposure.
Time-dependent changes in PMA-sensitive PKC membrane partitioning underlie the chronic inhibitory effects of PMA on apical membrane I SC -cAMP. The acute effects of high-dose PMA on monolayer transcellular I SC have previously been shown to be mediated by PKC-␣ (66) . In this series of experiments, we determined the status of the PMA-sensitive pool after a 24-h low-dose (50 nM) PMA exposure when Ͼ97% of apical membrane I SC -cAMP was inhibited (see Fig. 8 ). Changes in immunospecific PMA-sensitive PKC expression in both the cytosolic and membrane fractions were determined by Western blot analysis (Fig. 9) .
A modest but not significant increase in the PKC-␣ R (membrane/cytosol) , equal to 1.2 Ϯ 0.1 (n ϭ 4, untreated monolayers used for comparison), was recorded. Both PKC-␤ 1 and PKC-⑀ exhibited elevated R (membrane/cytosol) values (2.4 Ϯ 0.1 and 1.5 Ϯ 0.3, respectively) and were significantly different (P Ͻ 0.001; Fig. 9, A and B) . Thus both isoform pools were present in a chronically activated state. In contrast, PKC-␤ 2 membrane association was reduced by 2.7 Ϯ 0.2-fold. This statistically significant (P Ͻ 0.001, n ϭ 4) increase in the size of the inactive cytoplasmic PKC-␤ 2 pool mimicked that obtained after a 24-h DOPPA incubation (1.4-fold reduction, P Ͻ 0.05, n ϭ 4; Fig. 5B ).
When the total cellular levels of each isoform were immunoassayed (data not shown), more pronounced and significant decreases in PKC-␤ 1 (1.4 Ϯ 0.2-fold) and increases in PKC-␤ 2 (1.7 Ϯ 0.2-fold) expression were recorded. Changes in PKC-⑀ (1.2 Ϯ 0.1-fold) expression or the relative cellular levels of the other isoforms (PKC-␣ and PKC-␥) were not significant (P Ͻ 0.001, n ϭ 4). The percent membrane association [membrane/ (cytosol ϩ membrane) ϫ 100] for the PKC ␥-isoform remained unchanged at 22%, and a modest rise in PKC-␣ membrane association was recorded (from 50% to 59%). Values for the other isoforms either rose from 77% to 90% (PKC-⑀) or from 50% to 71% (PKc-␤ 1 ) or decreased from 90% to 79% (PKC-␤ 2 ).
Thus the larger apical membrane I SC -cAMP inhibitions recorded with the stronger agonist PMA were matched with greater changes in PKC-␤ cell signaling. However, in contrast to DOPPA and reflecting the less-specific effects of this agonist, PKC-⑀ activation was also implicated in the chronic inhibitory phenomena. Fig. 7 . Time course comparing the chronic effects of either the weak PKC agonist DOPPA (50 nM; F) or the strong PKC agonist PMA (50 nM; E) on FSK-stimulated ISC-cAMP generated by intact monolayers. A Ͻ2-h preincubation with carrier plus PMA reduced ISC to 15% of the untreated response, whereas in monolayers preincubated for 24 h with carrier plus DOPPA, 51% of the untreated ISC response remained (n ϭ 11-23 observations for each time point for DOPPA and 4 -6 observations of each time point for PMA). The downregulation of PKC-␤ 1 and PKC-⑀ by PMA was associated with recovery of apical plasma membrane I SCcAMP. To address in chronic PMA experiments whether PKC-⑀ along with PKC-␤ 1 /PKC-␤ 2 affected apical plasma membrane CFTR function, we attempted to selectively downregulate individual isoforms by increasing the dose and/or time of monolayer PMA exposure. This experiment was performed with the assumption that if an isoform was important, then, after its downregulation, a matching increase in cAMP-mediated apical plasma membrane CFTR anion channel function should occur. Given our DOPPA findings and reports indicating that epithelial cell PKC is more resistant to downregulation than nonepithelial cell PKC mass (33), we did not consider using a similar approach with the PKC-␤-specific but weaker agonist DOPPA. Increasing the preexposure time to 50 nM PMA from 24 to 48 h had little effect on apical membrane I SC -cAMP (data not shown). Similarly, increasing the monolayer PMA dose to 500 nM for 24 h only marginally affected apical membrane I SC -cAMP (inhibition was 90% of control monolayer response, data not shown). However, increasing both the PMA dose to 500 nM and prolonging the exposure time to 48 h clearly led to less-inhibitory effects on apical membrane I SC -cAMP in both membrane configurations [shown are results from basolateral plasma membrane-permeabilized monolayers (Fig. 10)] .
In Fig. 10 , a and b, the monolayers were maintained under symmetrical high (140 mM) NaCl gradients. A reversed 140:7 mM mucosal-to-serosal Cl Ϫ gradient was then established, and apical membrane I SC -cAMP was recorded. In control monolayers, the addition of Nystatin to the serosal bath reversed the direction of the apical membrane I SC -cAMP (Fig. 10A) . However, unlike the findings shown in Fig. 8 , PMA-preincubated monolayers exposed for an extended period at the higher dose exhibited a significant transcellular I SC -cAMP (Fig. 10b) . When changes were expressed as percent inhibition (Fig. 10B ), values were ϳ41% of the control untreated monolayer response compared with the Ͻ97% inhibition recorded in earlier protocols. No directional effects of anion gradient were present, and inhibitions were 63 Ϯ 5% and 56 Ϯ 2% for 140:7 mM serosal-to-mucosa and 140:7 mM mucosal-to-serosal Cl Ϫ gradients, respectively (n ϭ 8). Thus, compared with 24-h exposure to 50 nM PMA, an ϳ40% apical membrane I SCcAMP recovery occurred after 48-h exposure to 500 nM PMA.
A similar partial recovery, but at the level of transcellular I SC -cAMP, has been reported previously in intact HT-29 Cl.19A monolayers preincubated with high doses of PMA. This was attributed to regained basolateral K ϩ conduction upon cellular PKC-␣ depletion (66) . These results differ from our own findings in that we were unable to produce significant changes in the cellular mass of PKC-␣ at 24-h post-PMA exposure. The previous investigations did not determine direct PKC effects at the apical plasma membrane. Following their example, we assayed both total cellular (Triton X-100/SDS solubilized) PKC expression levels in the Triton X-100-solubilized cellular homogenate. The results are shown in Fig. 11 .
We found that both PKC-␤ 1 and PKC-⑀ exhibited decreased overall cellular expression (relative to control conditions, densitometry readings were 13% and 39% of untreated monolayer values, respectively, n ϭ 2). The cellular levels of the other isoforms (PKC-␣ and PKC-␤ 2 ) were not significantly altered (Fig. 11A) . Thus, while clearly demonstrating that PKC activation was required for the inhibition of apical membrane I SC -cAMP, the sensitivity of PKC-␤ 1 and PKC-⑀ to chronic downregulation by PMA was too similar to determine whether an individual isoform or both isoforms were responsible. However, given that 70% of the acute PMA-sensitive current could be protected by the highly selective PKC inhibitor Gö6976 (Table 3) , we propose that along with PKC-␣, PKC-␤ 1 /␤ 2 plays a major role in positively and negatively regulating cAMP-dependent secretory current generated by this membrane, respectively.
DISCUSSION
Biophysical studies have demonstrated that CFTR anion channel activity is regulated by PKC-dependent phosphorylation (for a review, see Ref. 22) . However, there are few details concerning which PKC isoforms participate in this response. In this study, we sought to determine whether phorbol ester use in vitro could provide us with such information.
Complexity in PKC signaling revealed. Our initial hypothesis was that PKC signaling in Cl Ϫ -secreting gastrointestinal HT-29 Cl.19A monolayers could be broken down into separate components through the use of either weak or strong PKC agonists. This initial assumption proved to be oversimplified. However, we were able to show that chronic (24 h) exposure to Fig. 9 . Postactivation status of cellular phorbol estersensitive PKC isoform membrane to cytoplasmic partitioning in monolayers preincubated for 24 h with 50 nM PMA. A: Western blots of PKC isoform expression in detergent-extracted membrane and cytosolic subcellular fractions isolated from control (blot i) or PMAtreated (blot ii) monolayers, demonstrating increases in the densitometric appearance of membrane-associated PKC ␣-, ␤1-, and ⑀-isoforms bands. Conversely, both membrane and cytosolic PKC-␤2 bands appeared to increase. B: corresponding bar graph of membrane-tocytosolic ratios (densitometric values relative to ␤-actin). All changes were clearly significant. Open bars, control monolayers; hatched bars, PMA-pretreated monolayers (n ϭ 3, P Ͻ 0.01).
the weak PKC-␤-specific agonist DOPPA downregulated apical plasma membrane CFTR-dependent I SC while failing to induce direct CFTR Cl Ϫ channel activation (Figs. 3 and 4 and  Table 3 ). These effects were accompanied by a shift in the total PKC isoform mass toward postactivation status, leading to increased cellular PKC-␤ 2 expression/cytoplasmic partitioning and decreased cellular PKC-␤ 1 content (Fig. 5) . Similar changes were not recorded for other PKC isoforms (either conventional or novel). We also found that chronic exposure to Ͻ30 nM DOPPA potentiated CCh effects on transcellular I SC -cAMP, a phenomena mediated by a Ba 2ϩ -sensitive transport event localized at the basolateral plasma membrane (Table  1) . On the basis of previous studies in this cell line (see the Introduction) and the well-established sensitivity of K ϩ but not Cl Ϫ channels to this divalent cation (21), we attributed this relief from inhibition to be due to PKC-␤-sensitive stimulation of basolateral K ϩ channel and/or accompanying Na
Ϫ cotransport function (21, 22, 24, 25) . However, given that this was not our focus, this phenomenon was not investigated further.
The more effective but nonspecific agonist PMA (50 nM) acutely stimulated apical plasma membrane-generated I SC (Fig.  6 ) and caused significant downregulation of apical membrane I SC -cAMP induced by FSK within 2-h preexposure (Fig. 7) . These changes were accompanied by activation of a wider range of PKC isoforms (PKC-␣, -␤ 1 , and -⑀; Fig. 9 ) than with DOPPA. Because 70% of the acute PMA-stimulated current was sensitive to the highly selective PKC-␣/␤ antagonist Gö6976 (Table 4) , PKC-␣ and/or PKC-␤ 1 were predicted to be major participants in I SC under these conditions. Moreover, our earlier findings that the ␤-isoform-specific agonist DOPPA did not acutely stimulate apical plasma membrane I SC (Table 3) further identified PKC-␣ as the most likely candidate for CFTR-mediated current activation.
Compared with DOPPA, the overall effects of chronic (24 h) low-dose (50 nM) PMA on transcellular I SC -cAMP (Fig. 8) and on cellular PKC-␤ 2 expression/membrane partitioning were similar but potentiated. However, unlike DOPPA, the nonspecificity of this agonist led to the activation of three additional PKC isoforms (PKC-␣, -␤ 1 , and -⑀; Fig. 9 ) and intro- Fig. 10 . Effects of chronic (48 h) high-dose PMA (500 nM) preincubation on FSK-stimulated ISC generated by basolateral membrane ion-permeabilized monolayers. A: monolayers were preincubated with carrier alone (a) or carrier plus 500 nM PMA (b). Initially, both mucosal and serosal baths contained 140 mM NaCl. I, change to 7 mM serosal bath NaCl; ii, bilateral addition of 10 M FSK; iii, serosal bath addition of Nystatin (50 mg/ml); iv, mucosal bath addition of 1 mM DPC. Chronic, high-dose PMA stimulation led to a partial recovery of ISC previously inhibited by lower doses of this agonist (Fig. 8 ). *Effects of 10 M CCh on FSK-stimulated apical membrane ISC under these conditions; 26% of all (control, DOPPA, and PMA) monolayers exhibited a small additional current component, and the rest either exhibited no CCh effect (59%) or a slight inhibition (15%) (n ϭ 50). B: DPC-sensitive ISC responses replotted as a bar graph of the %inhibition of the untreated monolayer FSK ISC-cAMP response after 48-h monolayer preincubation with 500 nM PMA (P2). Irrespective of the direction to the prevailing ionic gradient [140:7 mM serosal to mucosal (bar i); 140:7 mM mucosal to serosal (bar ii)], chronic PMA stimulation at the higher dose (P2) led to a 61 Ϯ 3% and 56 Ϯ 5% inhibition, respectively (n ϭ 4, values are means Ϯ SD). duced further complexity into the system. To address the question of multiple cellular inhibitory pathways, differing in their time course of activity, we looked for both chronic effects of PMA on PKC isoform mass/apical membrane I SC -cAMP inhibition in control and agonist-treated monolayers [and determined the subcellular location of CFTR anion channels; see companion study (9a)]. Exposing monolayers for an extended time period (48 h) to high (500 nM) PMA doses selectively reduced cellular PKC-␤ 1 and PKC-⑀ content (Fig. 11) and induced a partial (ϳ40%) recovery in apical plasma membrane-generated I SC -cAMP (Fig. 10) . These findings predicted a role for PKC-␤ 1 , but not PKC-␤ 2 or PKC-␣, in uncoupling the FSK-generated cAMP signal from apical plasma membrane CFTR activity. They also highlighted PKC-⑀ as an alternative candidate. In the airway-derived cell line Calu-3, PKC-⑀ stimulated a cAMP-dependent activation of CFTR-mediated Cl Ϫ efflux (34), whereas, in colonocytes, PKC-⑀ has been shown to mediate phorbol ester-induced inhibition of Cl Ϫ /OH Ϫ exchange (56) , and, in duodenal mucosal sheets from SwissWebster mice, cAMP potentiated bicarbonate transport (63) . In the context of CFTR-mediated Cl Ϫ secretion, PKC-␤ 1 is the candidate for chronic phorbol ester-dependent inhibition of apical plasma membrane CFTR-mediated secretory current.
Evidence favoring PKC-␤ 1 as a negative modulator of apical plasma membrane CFTR function. The inhibitory effects of PMA in the intact cell (Fig. 7) and on apical plasma membrane-generated I SC -cAMP were Ͼ80% complete within 2 h. This time course was much faster than that required for brefeldin A (BFA) (42) or DOPPA effects on apical plasma membrane CFTR targeting with the cellular biosynthetic pathway [PKC-␤ 2 dependent; see companion study (9a)]. In addition, the after PMA-induced downregulation of PKC-␤ 1 (Fig.  9) , the corresponding recovery in apical plasma membranegenerated I SC -cAMP (Fig. 10 ) occurred in monolayers exhibiting CFTR immunostaining below detectable limits within the apical pole of the cell [companion study (9a) ]. These facts argue for a separate inhibitory locus at, or below, the apical plasma membrane leaflet.
Three ␤-stands within the C2 region of PKC-␤, which are also shared with other PKCs, function as the minimal RACKbinding domain (41) . Peptides made against these regions inhibit the movement of all C2 domain-containing PKCs and have been shown to prevent phorbol ester-mediated L-type Ca 2ϩ channel downregulation in cardiac myocytes (69) . PKC activation in these cells leads to both stimulation of Ca 2ϩ channel activity and recruitment of Ca 2ϩ channels to the plasma membrane (68) . The PDZ-binding domain in the COOH-terminus of CFTR is known to interact with cytoskeletal elements and numerous PDZ domain-containing binding partners, which are hypothesized to maintain CFTR localization and function at the apical plasma membrane (32) . Of these binding partners, PKC-dependent phosphorylation of EPB50/ NHERF has been shown to decrease CFTR channel opening, resulting in inhibition of CFTR currents in airway epithelial cells (53) . Both PKC-␤ and PKC-⑀ are known to interact with RACK1 (35, 41) . PKC-⑀ has been proposed to mediate the stimulation of cAMP-dependent CFTR activity, whereas, as we show here, PKC-␤ 1 paradoxically appears to mediate inhibition of cAMP-dependent CFTR activity. Thus we propose that both isoforms may act in concert to reciprocally regulate CFTR through the phosphorylation of target proteins interacting with CFTR close to or at the apical plasma membrane.
Several lines of evidence support a physiological role for the regulation of CFTR by controlled insertion in the apical membrane. CFTR exists in a rapidly recycling endocytic pool (52) . Removal of the internalization signals from the COOH terminal of the CFTR increases expression at the cell surface (50) . cAMP stimulates activation of the membrane resident pool of the CFTR channel and trafficking of a vesicular pool of CFTR near the apical membrane (62) and may decrease endocytic retrieval of apical membrane-resident CFTR (31, 37, 45, 52) . Using a highly sensitive cryoimmunogold labeling technique and electron microscopy, Ameen and colleagues (1) have recently identified CFTR in subapical vesicles and at the apical plasma membrane in rat intestinal crypt cells. cAMP stimulation in the rat proximal small intestine resulted in fluid secretion and apical pole CFTR redistribution (1) . Thus, in the latter instance, the PKC dependency to CFTR function at the apical plasma membrane reported in the present study provides a mechanistic basis for the movement of CFTR observed in these ex vivo studies.
Other forms of regulation not involving a direct association of PKC with signaling complexes interacting with channels at the channel membrane can be considered. A BFA-insensitive (nonconstitutive) exocytotic mechanism is utilized by neuronal cells to functionally upregulate N-type Ca 2ϩ channel activity through mechanisms involving vesicle delivery to the plasma membrane (65) . Syntaxin-1 and associated modulator proteins (13) have been shown to functionally upregulate a variety of plasma membrane proteins including 1) adipocyte and smooth muscle insulin-regulated glucose uptake mediated by the glucose transporter GLUT4 (49); 2) a variety of neurotransmitter transporters (14, 25) ; and 3) CFTR expression in oocytes (47) , in cultured tracheal epithelial cells, and in T84 gastrointestinal epithelial cells (46) . Both GLUT4 and CFTR/syntaxin-1 association in vitro are inhibited by the modulator protein Munc-18, which reverses syntaxin-dependent inhibition of both insulin-stimulated glucose transport (for a review, see Ref. 49 ) and cAMP-regulated anion channel current (47), respectively. Interestingly, PKC phosphorylation of Munc-18 in cell-free systems results in prevention of its interaction with syntaxin-1 (21) and has been shown in vitro to increase the availability of syntaxin for GABA neurotransmitter transporter binding and subsequent functional downregulation (7) .
Fluid-secreting HT-29 Cl.19A monolayers do not exhibit high levels of PKC-regulated apical plasma membrane exocytosis (43) . However, taken together, these facts may provide a mechanistic basis for the PKC-␤ 1 inhibitory effects on transcellular I SC -cAMP: PKC-␤ 1 acting through phosphorylation of a related modulatory protein within late stages the constitutive biosynthetic pathway could prevent or stabilize a subapical plasma membrane pool of CFTR undergoing membrane insertion. Our finding that the PKC inhibitor Gö6976 transiently protected a pool of CFTR not already associated with the apical plasma membrane (Table 3 ) may relate to this phenomena.
The hypothesized role of PKC-␤ 1 in plasma membraneresident cAMP signal/CFTR coupling or subplasma membrance vesicle fusion would not be mutually exclusive.
Evidence for a possible role for PKC-⑀ in the cellular regulation of apical plasma membrane-generated I SC . Finally, our results do not exclude a possible role for PKC-⑀ in both the stimulation and inhibition of apical plasma membrane-generated CFTR Cl Ϫ current because PKC-⑀, like PKC-␤ 1 , was downregulated after a high-dose PMA exposure (Fig. 10) in monolayers exhibiting partial recovery of apical plasma membrane I SC -FSK (Fig. 11) . Actin-binding PKC-⑀ (51) has been implicated in CCh-stimulated apical membrane exocytosis in rabbit lacrimal acini (15) as well as the regulated endocytotic retrieval of Shaker K ϩ channels in oocytes (9) , in basolateral plasma membrane endocytosis (61) , and in the inhibitory effects of EGF on CCh-mediated basolateral K ϩ channel stimulation in T84 monolayers (12) . In both later instances (17) , the authors surmised that elevated basolateral membrane internalization could account for the PMA-dependent inhibition of monolayer anion secretion. A cellular locus for PKC-⑀'s effects may involve the actin-binding protein coronin se (48) , which binds ezrin in vitro and is also a cellular target for PKC-⑀ phosphorylation. Thus, although PKC-⑀ modulation of goblet epithelial cell mucin exocytosis (26) and cAMP-regulated Cl Ϫ efflux in cultured Calu-3 airway epithelial cells is established (34), we presently favor the hypothesis that, in colonocytes, the primarily locus of PKC-⑀ regulation is the basolateral plasma membrane.
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